A retrospective trial to assess the effect of liraglutide in obese patients with type 2 diabetes mellitus on obstructive sleep apnoea symptoms

Trial Profile

A retrospective trial to assess the effect of liraglutide in obese patients with type 2 diabetes mellitus on obstructive sleep apnoea symptoms

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2014

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Nov 2014 New trial record
    • 18 Sep 2014 Primary endpoint 'Epworth Sleepiness Scale' has been met according to results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
    • 18 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top